ReviewiScience2026
Multi-omics landscapes across the gastritis-to-carcinoma sequence: Stage-specific molecular evolution and microenvironmental remodeling.
Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The progression from chronic gastritis to gastric cancer is a complex and multistep process. Early detection of this transition is critical for improving patient survival; however, the underlying molecular mechanisms remain incompletely understood. Recent advances in multi-omics technologies have provided powerful tools for high-resolution characterization of disease-associated molecular alterations. In this review, we summarize studies investigating the gastritis-to-carcinoma sequence using genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiome analyses. Particular emphasis is placed on evidence from human cohorts, single-cell sequencing, and spatial transcriptomics, which have helped characterize cellular heterogeneity, immune microenvironment remodeling, and cell-cell interactions. We also discuss the role of the microbiome, particularly
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.